ESSA Pharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2024 | 4 | -$0.25 | -$0.15 | -$0.19 |
| Q3 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2025 | 2 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
ESSA Pharma Inc. Earnings Date And Information
ESSA Pharma Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.26 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ESSA Pharma Inc. has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -2.74. ESSA Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 10th, 2024 based on prior year's report dates.
ESSA Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2024 | Q3 2024 | -$0.26 | -$0.16 | 0.1 | $0 | $0 |
| 05/14/2024 | Q2 2024 | -$0.19 | -$0.20 | -0.01 | $0 | |
| 02/13/2024 | Q1 2024 | -$0.17 | -$0.14 | 0.03 | $0 | |
| 12/12/2023 | Q4 2023 | -$0.22 | -$0.12 | 0.1 | $0 | |
| 08/08/2023 | Q3 2023 | -$0.20 | -$0.17 | 0.03 | $0 | |
| 05/09/2023 | Q2 2023 | -$0.20 | -$0.16 | 0.04 | $0 | |
| 02/07/2023 | Q1 2023 | -$0.24 | -$0.15 | 0.09 | $0 | |
| 12/13/2022 | Q4 2022 | -$0.28 | -$0.14 | 0.14 | $0 | |
| 08/04/2022 | Q3 2022 | -$0.27 | -$0.20 | 0.07 | $0 | |
| 05/10/2022 | Q2 2022 | -$0.25 | -$0.24 | 0.01 | $0 | |
| 02/03/2022 | Q1 2022 | -$0.23 | -$0.21 | 0.02 | $0 | |
| 11/18/2021 | Q4 2021 | -$0.23 | -$0.21 | 0.02 | $0 | |
| 08/16/2021 | Q3 2021 | -$0.26 | -$0.21 | 0.05 | $0 | |
| 05/06/2021 | Q2 2021 | -$0.21 | -$0.36 | -0.15 | $0 | |
| 02/11/2021 | Q1 2021 | -$0.17 | -$0.20 | -0.03 | $0 | |
| 12/15/2020 | Q4 2020 | -$0.20 | -$0.17 | 0.03 | $0 | |
| 07/15/2020 | Q3 2020 | -$0.24 | $0 | |||
| 04/13/2020 | Q2 2020 | -$0.20 | -$0.45 | -0.25 | $0 | |
| 02/10/2020 | Q1 2020 | -$0.22 | $0 | |||
| 12/19/2019 | Q4 2019 | -$0.07 | $0 |
ESSA Pharma Inc. Earnings: Frequently Asked Questions
-
When is ESSA Pharma Inc.'s earnings date?
ESSA Pharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 10th, 2024 based off last year's report dates.
-
Did ESSA Pharma Inc. beat their earnings estimates last quarter?
In the previous quarter, ESSA Pharma Inc. (:EPIX) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.26 by $0.1.
-
How can I listen to ESSA Pharma Inc.'s earnings conference call?
The conference call for ESSA Pharma Inc.'s latest earnings report can be listened to online.
-
How can I read ESSA Pharma Inc.'s conference call transcript?
The conference call transcript for ESSA Pharma Inc.'s latest earnings report can be read online.
-
How much profit does ESSA Pharma Inc. generate each year?
ESSA Pharma Inc. (:EPIX) has a recorded net income of $0. ESSA Pharma Inc. has generated $-0.6 earnings per share over the last four quarters.
-
What is ESSA Pharma Inc.'s price-to-earnings ratio?
ESSA Pharma Inc. (:EPIX) has a price-to-earnings ratio of -2.74 and price/earnings-to-growth ratio is -1.73.
